Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients

By                    

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 181-187

Spandidos Publications

Access to resources Recommend Favorite

In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase

By              

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 791-796

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of Cytopenias Occurring in Imatinib Treated Chronic Myeloid Leukemia (CML) Patients

By Paul T.  

Indian Journal of Hematology and Blood Transfusion, Vol. 26, Iss. 2, 2010-06 ,pp. : 56-61

Springer Publishing Company

Access to resources Recommend Favorite

Intracellular cytokine analysis of interferon-γ in T cells of patients with chronic myeloid leukemia

By Aswald Jorg M   Lipton Jeffrey H   Messner Hans A  

Cytokines, Cellular & Molecular Therapy, Vol. 7, Iss. 2, 2002-12 ,pp. : 75-83

Informa Healthcare

Access to resources Recommend Favorite

Imatinib and chronic myeloid leukemia: close to the bone

By Terpos Evangelos  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1581-1582

Informa Healthcare

Access to resources Recommend Favorite